Technology platform

Integrated tools for biomarker discovery and immunotherapy development.

MIORG’s technology platform combines molecular profiling, functional immunology, and translational interpretation to support both predictive and therapeutic oncology programs.

Platform philosophy

Build evidence through layered biology rather than isolated readouts.

Core capabilities

From immune profiling to functional validation.

01

RNA/DNA immune profiling

Focused immune signatures designed to reveal response-relevant biology in clinically meaningful settings.

02

Gene signatures and TMB integration

Multidimensional interpretation instead of dependence on a single biomarker category.

03

Spatial transcriptomics

Support for location-aware immune biology and tumor microenvironment interpretation.

04

Proteomics

Protein-level insights to complement molecular signatures and pathway hypotheses.

05

Digital pathology

Structured tissue interpretation for translational development and biomarker framing.

06

Machine learning

Analytical methods to support signal integration, prioritization, and predictive modeling work.

07

Functional immunology

Assays intended to test biological meaning, not only statistical association.

08

Dendritic cell assays

Mechanism-relevant testing tied to antigen presentation and antitumor T-cell generation.

09

Preclinical tumor models

Resistant-model evaluation to support program refinement and combination hypotheses.

MIORG technology and laboratory infrastructure
Clinical integration

Technology intended to connect bench insight with clinical relevance.

MIORG’s platform is not limited to discovery. It is structured to support validation design, partner communication, and clinically meaningful development hypotheses that can translate into diagnostics, combination strategies, or collaboration frameworks.

  • Clinical cohort integration
  • Biomarker prioritization
  • Mechanistic interpretation
  • Program design support
  • Partnership-readiness